Cargando…
Long-Term Survival of Over 6 Years with Afatinib Sequential Treatment in a Patient with EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Case Report
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149342/ https://www.ncbi.nlm.nih.gov/pubmed/33861418 http://dx.doi.org/10.1007/s40261-021-01025-6 |
| _version_ | 1783697941176778752 |
|---|---|
| author | Tu, Hai-Yan Li, Yang-Si Yang, Jin-Ji Chen, Hua-Jun Jiang, Ben-Yuan Zhong, Wen-Zhao Yang, Xue-Ning Wu, Yi-Long |
| author_facet | Tu, Hai-Yan Li, Yang-Si Yang, Jin-Ji Chen, Hua-Jun Jiang, Ben-Yuan Zhong, Wen-Zhao Yang, Xue-Ning Wu, Yi-Long |
| author_sort | Tu, Hai-Yan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8149342 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-81493422021-06-01 Long-Term Survival of Over 6 Years with Afatinib Sequential Treatment in a Patient with EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Case Report Tu, Hai-Yan Li, Yang-Si Yang, Jin-Ji Chen, Hua-Jun Jiang, Ben-Yuan Zhong, Wen-Zhao Yang, Xue-Ning Wu, Yi-Long Clin Drug Investig Research Letter Springer International Publishing 2021-04-16 2021 /pmc/articles/PMC8149342/ /pubmed/33861418 http://dx.doi.org/10.1007/s40261-021-01025-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
| spellingShingle | Research Letter Tu, Hai-Yan Li, Yang-Si Yang, Jin-Ji Chen, Hua-Jun Jiang, Ben-Yuan Zhong, Wen-Zhao Yang, Xue-Ning Wu, Yi-Long Long-Term Survival of Over 6 Years with Afatinib Sequential Treatment in a Patient with EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Case Report |
| title | Long-Term Survival of Over 6 Years with Afatinib Sequential Treatment in a Patient with EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Case Report |
| title_full | Long-Term Survival of Over 6 Years with Afatinib Sequential Treatment in a Patient with EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Case Report |
| title_fullStr | Long-Term Survival of Over 6 Years with Afatinib Sequential Treatment in a Patient with EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Case Report |
| title_full_unstemmed | Long-Term Survival of Over 6 Years with Afatinib Sequential Treatment in a Patient with EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Case Report |
| title_short | Long-Term Survival of Over 6 Years with Afatinib Sequential Treatment in a Patient with EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Case Report |
| title_sort | long-term survival of over 6 years with afatinib sequential treatment in a patient with egfr mutation-positive non-small cell lung cancer: a case report |
| topic | Research Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149342/ https://www.ncbi.nlm.nih.gov/pubmed/33861418 http://dx.doi.org/10.1007/s40261-021-01025-6 |
| work_keys_str_mv | AT tuhaiyan longtermsurvivalofover6yearswithafatinibsequentialtreatmentinapatientwithegfrmutationpositivenonsmallcelllungcanceracasereport AT liyangsi longtermsurvivalofover6yearswithafatinibsequentialtreatmentinapatientwithegfrmutationpositivenonsmallcelllungcanceracasereport AT yangjinji longtermsurvivalofover6yearswithafatinibsequentialtreatmentinapatientwithegfrmutationpositivenonsmallcelllungcanceracasereport AT chenhuajun longtermsurvivalofover6yearswithafatinibsequentialtreatmentinapatientwithegfrmutationpositivenonsmallcelllungcanceracasereport AT jiangbenyuan longtermsurvivalofover6yearswithafatinibsequentialtreatmentinapatientwithegfrmutationpositivenonsmallcelllungcanceracasereport AT zhongwenzhao longtermsurvivalofover6yearswithafatinibsequentialtreatmentinapatientwithegfrmutationpositivenonsmallcelllungcanceracasereport AT yangxuening longtermsurvivalofover6yearswithafatinibsequentialtreatmentinapatientwithegfrmutationpositivenonsmallcelllungcanceracasereport AT wuyilong longtermsurvivalofover6yearswithafatinibsequentialtreatmentinapatientwithegfrmutationpositivenonsmallcelllungcanceracasereport |